Syncope, or transient loss of consciousness (TLOC), is a common clinical presentation with a myriad of potential causes. It is often challenging for healthcare professionals to diagnose due to its transient nature and broad differential. This article aims to provide a comprehensive approach to the evaluation and management of syncope.
Syncope is defined as a brief, self-limited loss of consciousness, usually leading to a fall. It is characterized by a rapid onset, short duration, and spontaneous complete recovery. It results from a transient decrease in blood flow to the brain, typically due to a failure in cardiovascular autoregulation.
Syncope can be broadly classified into three categories: reflex (or neurally mediated), orthostatic hypotension, and cardiac syncope. Reflex syncope includes vasovagal, situational, carotid sinus hypersensitivity, and atypical forms. Orthostatic hypotension can be further divided into primary and secondary types, while cardiac syncope includes arrhythmias and structural heart disease.
The diagnosis of syncope starts with a detailed history and physical examination, focusing on identifying features suggestive of specific causes. Diagnostic tests such as electrocardiogram (ECG), echocardiogram, tilt-table testing, and carotid sinus massage can be useful. In some cases, more advanced investigations like implantable loop recorders may be needed.
The management of syncope depends on the underlying cause. For reflex syncope, lifestyle modifications and patient education are key. Orthostatic hypotension may require medication adjustments, while cardiac syncope often necessitates specific interventions like pacemaker implantation or antiarrhythmic therapy.
Syncope is a complex clinical entity with a wide range of potential causes. A systematic approach to its evaluation can help healthcare professionals identify the underlying cause and guide appropriate management, ultimately improving patient outcomes.
1.
Stem Cell Selection Unneeded for SSc Transplant Therapy?
2.
Radiation from CT scans could account for 5% of all cancer cases a year, study suggests
3.
Do I have prostate cancer? Why a simple PSA blood test alone won't give you the answer
4.
In Hemophilia A and B, a Novel Monoclonal Antibody Reduces Bleeding.
5.
Tumor infiltration of major blood vessels, not metastasis, may be primary cause of cancer death
1.
Revolutionizing Oncology Trials: Optimization, Matching, Diversity, and Decentralization
2.
Emerging Dysregulated Signaling Pathways in Early-Onset Colorectal Cancer
3.
Exploring the Use of Bevacizumab in Treating Different Types of Cancers
4.
A Closer Look at Poorly Differentiated Carcinoma: Uncovering its Complexities
5.
Unlocking the Secrets of Squamous Cell Carcinoma: New Hope for Patients
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
INO-VATE: The Long-Term Overall Survival Analysis in Iontuzumab-Treated Patients
2.
The Era of Targeted Therapies for ALK+ NSCLC: A Paradigm Shift
3.
A New Era in Managing Cancer-Associated Thrombosis
4.
Navigating the Complexities of Ph Negative ALL - Part IX
5.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VIII
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation